BioSig appoints med device veteran James Barry as independent director

Streamex Corp.

James J. Barry, Ph.D., appointed to Board effective Sept 20, 2021, filling expanded 7-member board.
Dr. Barry has 30+ years in med devices; former SVP at Boston Scientific, President/CEO at InspireMD and Arsenal Medical.
Received 50,000 RSUs—50% vested immediately, 50% on first anniversary.
Over 60 physicians have completed 1,300+ patient cases with PURE EP system across 12 clinical sites.
Commercial launch focused in Northeast, Texas, Florida; in use at Mayo Clinic and St. David's Medical Center.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

James J. Barry

director

STEX · Streamex Corp.

Effective: 2021-09-20
Filed: September 22, 2021, 7:59 PM ET

On September 20, 2021, the board of directors (the “Board”) of BioSig Technologies, Inc. (the “Company”) appointed James J. Barry, Ph.D. as a director of the Company, effective as of the same date

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

James J. Barry was appointed as director at Streamex Corp..

Action: appointed
Role: director

Exact text from the filing

On September 20, 2021, the board of directors (the “Board”) of BioSig Technologies, Inc. (the “Company”) appointed James J. Barry, Ph.D. as a director of the Company, effective as of the same date

View on SEC.gov

Streamex Corp. filing history →

Source: SEC EDGAR

accession 0001185185-21-001333

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.